Biapenem 300 mg / 600 mg* --- under development

Biapenem 300 mg / 600 mg* --- under development
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem 300 mg / 600 mg* --- under development. It belobgs to carbapenem finish formulations products category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Azithromycin dihydrate

    Product Azithromycin dihydrate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes azithromycin dihydrate. It belongs to lypholised powder ready to fill category. Contact us for more information.
  • Aztreonam + l ? arginine

    Product Aztreonam + l ? arginine

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aztreonam + l ? arginine. It belongs to antibacterial ( betalactum ) apis products category. Contact us for more information.
  • Balofloxacin

    Product Balofloxacin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes balofloxacin. It belongs to quinolone apis products category. Contact us for more information.
  • Bendamustin hcl

    Product Bendamustin hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustin hcl. It belongs to antineoplastic apis category. Contact us for more information.
  • Bendamustine 100 mg*

    Product Bendamustine 100 mg*

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bendamustine 100 mg*. It belongs toalyophilised injections finish formulations products category. Contact us for more information.
  • Besifloxacin

    Product Besifloxacin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes besifloxacin. It belongs to quinolone apis products category. Contact us for more information.
  • Biapenem*

    Product Biapenem*

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem*. It belongs to antibacterial ( betalactum ) apis products category. Contact us for more information.
  • Bicalutamide

    Product Bicalutamide

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide. It belongs to antineoplastic apis category. Contact us for more information.
  • Bicalutamide tablets 50 mg

    Product Bicalutamide tablets 50 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide tablets 50 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.
  • Bimatoprost

    Product Bimatoprost

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bimatoprost. It belongs to antiglaucoma apis products category. Contact us for more information.
  • Bivalirudin

    Product Bivalirudin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin. It belongs to anticoagulant apis category. Contact us for more information.
  • Bivalirudin 250 mg inj

    Product Bivalirudin 250 mg inj

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin 250 mg inj. It belongs to cardiac finish formulations products category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)